NZOZ IGNIS dr med. Alicja Łobinska
- Address
- lock Available on a paid plan
NZOZ IGNIS dr med. Alicja Łobinska - Epilepsy Research Center
NZOZ IGNIS dr med. Alicja Łobinska is a specialized neurological research center focused on advancing treatment options for patients with epilepsy disorders. The center demonstrates expertise in evaluating novel therapeutic interventions for patients with challenging seizure conditions, particularly those who have not responded adequately to conventional treatment approaches.
- Refractory focal onset epilepsy treatment studies
- Safety and tolerability evaluation of investigational antiepileptic medications
- Clinical research in treatment-resistant seizure disorders
The research facility specializes in conducting clinical trials for patients with refractory epilepsy, focusing on innovative compounds that may provide therapeutic benefits when standard medications have proven insufficient. Through rigorous safety and tolerability assessments, the center contributes valuable data to the development of next-generation antiepileptic therapies, offering hope to adult patients living with difficult-to-control focal onset seizures.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Biohaven Therapeutics Ltd.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in NZOZ IGNIS dr med. Alicja Łobinska
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of EDP-938 (Zelicapavir) Efficacy and Safety in Non-Hospitalized Adults with Acute Respiratory Syncytial Virus Infection at High Risk for Complications | Enanta Pharmaceuticals Inc. | Phase II | Not Recruiting | Feb 2023 | Jun 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bhv-7000 | 1 | Unknown | 2024-12-18 | 2024-12-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.